Molecular mechanisms driving lineage plasticity in prostate cancer: NANOG and beyond is a research paper published in Cancer Heterogeneity and Plasticity (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01CA272483-02
Targeting the Plk1/Pdcd4/mTORC2 Signaling to Treat Castration-Resistant Prostate Cancer
National Institutes of Health
Grant: 5R01CA196634-10
Improving chemotherapy of castration-resistant prostate cancer.
National Institutes of Health
Grant: 5R01CA256893-04
Enhancing the efficacy of androgen signaling inhibitors in prostate cancer
National Institutes of Health
Grant: 5R01CA157429-12
Overcoming Drug Resistance of Castration-Resistant Prostate Cancer
National Institutes of Health
Grant: 5R01CA264652-05
Plk1 as a prognostic biomarker for prostate cancer
FWCI
0.00
Citation Percentile
0.3%
Fields of Study
Keywords
Sustainable Development Goals